Mucormycosis also known as black fungus infection, can occur any time after COVID-19 infection, either during the hospital stay or several days to a couple of weeks after discharge. Doctors believe mucormycosis, which has an overall mortality rate of 50%, may be being triggered by the use of steroids, a life-saving treatment for severe and critically ill Covid-19 patients.
Steroids reduce inflammation in the lungs for Covid-19 and appear to help stop some of the damage that can happen when the body's immune system goes into overdrive to fight off coronavirus. But they also reduce immunity and push up blood sugar levels in both diabetics and non-diabetic Covid-19 patients. It's thought that this drop in immunity could be triggering these cases of mucormycosis.
Amphotericin B used in adjutant therapy to treat mucormycosis during/after Covid.
SimSon Pharma is offering Reference standards of Amphotericin B, Its impurities and stable isotopesto speed up the research and quality control.